AL
ALX Oncology Holdings Inc.
ALXO · NASDAQ
$2.01 -0.50% (-$0.01)
1M -2.43%
Market Cap $270.5M
P/E Ratio -
Div. Yield -
ROE 90.30%
Bulios Fair Price
$1.72
14.4% downside
Trenutna cena
$2.01
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ALXO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
88 /100
Cheap P/B 1.99x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 53.80%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 56.53%
Asset turnover 0.00x
ROE 90.30%
Debt
69 /100
Low Debt/Equity 0.07x
Int. coverage -56.49x
Current ratio 9.71x
Stability
47 /100
Moderate Beta 0.40x
Profitable years 0
EPS volatility 30.18%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALXO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Lettmann
Employees
48
Headquarters
South San Francisco
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report